Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.42 |
| ▸ | GABRP | O00591 | 1/20 | 0.42 |
| ▸ | GABRD | O14764 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.42 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29582311 | 1.00 | NPC1 (0.44) | NPC1CYP2D6CYP2C19CYP1A2HPGD | |
| Ammonia Solution, Strong SCHEMBL7212028 | 0.98 | NPC1 (0.43) | NPC1CYP2D6CYP2C19CYP1A2HPGD | |
| SCHEMBL6803 | 0.89 | CYP2C19 (0.56) | NPC1CYP2D6CYP2C19CYP1A2HPGD | |
| SCHEMBL29379587 | 0.89 | CYP2C19 (0.56) | NPC1CYP2D6CYP2C19CYP1A2HPGD | |
| SCHEMBL423447 | 0.88 | CYP2D6 (0.50) | NPC1CYP2D6CYP2C19CYP1A2RAB9A | |
| SCHEMBL2276388 | 0.88 | TSHR (0.43) | NPC1CYP1A2HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL4190714 | 0.86 | KDM4E (0.50) | NPC1CYP2D6CYP2C19CYP1A2HPGD | |
| SCHEMBL4885285 | 0.86 | SOAT1 (0.49) | NPC1CYP2D6CYP2C19CYP1A2RAB9A | |
| SCHEMBL21494430 | 0.86 | SOAT1 (0.49) | NPC1CYP2D6CYP2C19CYP1A2RAB9A | |
| SCHEMBL675902 | 0.86 | SOAT1 (0.49) | NPC1CYP2D6CYP2C19CYP1A2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230286913-A1 | INHIBITORS OF NITRIC OXIDE SYNTHASES (NOS), PHARMACEUTICAL PRODUCTS THEREOF, AND METHODS THEREOF | Gacter Inc. (US) | 2023-09-14 | — | — | US | claimed |
| CN-104311580-A | One-dimensional zinc-containing polymer and preparation method thereof | ZHANG JUNFENG | 2015-01-28 | — | — | CN | claimed |
| CN-104311581-A | One-dimensional zinc-containing polymer and preparation method thereof | ZHANG JUNFENG | 2015-01-28 | — | — | CN | claimed |
| CN-103664606-A | Preparation methods of flurbiprofen axetil compound | GUANGDONG JIABO PHARMACEUTICAL CO LTD | 2014-03-26 | — | — | CN | claimed |
| CN-1132832-C | Prepn process of 3-methyl-4 [(3-methoxy) propoxy]2-radical-methyl-thio-benzimidazole | SHANDONG XINHUA PHARMACEUTICAL (CN) | 2003-12-31 | — | — | CN | claimed |
| CN-1370771-A | Prepn process of 3-methyl-4 [(3-methoxy) propoxy]2-radical-methyl-thio-benzimidazole | SHANDONG XINHUA PHARMACEUTICAL (CN) | 2002-09-25 | — | — | CN | claimed |
| EP-0204535-B1 | N-FLUOROPYRIDINIUM SALT AND PROCESS FOR PREPARING SAME | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1992-08-19 | — | — | EP | claimed |
| JP-10167908-A | — | — | None | — | — | JP | disclosed |
| EP-4318630-B1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS SECONDARY BATTERY | ASAHI CHEMICAL IND (JP) | 2025-10-22 | — | — | EP | disclosed |
| US-20250122172-A1 | SUBSTITUTED PYRIDINE AND PYRAZINE COMPOUNDS AS PDE4 INHIBITORS | DART NEUROSCIENCE LLC | 2025-04-17 | — | — | US | disclosed |
| US-12199280-B2 | Non-aqueous secondary battery and non-aqueous electrolyte | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-01-14 | — | — | US | disclosed |
| EP-4415105-A2 | NON-AQUEOUS SECONDARY BATTERY AND NON-AQUEOUS ELECTROLYTE | Asahi Kasei Kabushiki Kaisha (JP) | 2024-08-14 | — | — | EP | disclosed |
| US-20240178452-A1 | Nonaqueous Electrolyte Solution and Nonaqueous Secondary Battery | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2024-05-30 | — | — | US | disclosed |
| US-4996320-A | Thyroid inhibitors | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1991-02-26 | — | — | US | disclosed |
| CN-1044812-A | The preparation method of chloroaniline derivative | GLAXO GROUP LTD (GB) | 1990-08-22 | — | — | CN | disclosed |
| CN-87101830-A | DICHLOROANILINE DERIVATIVES | — | 1987-09-09 | — | — | CN | disclosed |
| CN-86102700-A | The preparation method of pyridazinone derivative and desinsection thereof, kill mite, nematicide, fungicide composition | — | 1986-12-17 | — | — | CN | disclosed |
| EP-0204535-A1 | N-fluoropyridinium salt and process for preparing same | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1986-12-10 | — | — | EP | disclosed |
| CN-85109303-A | The 2-phenylpyran is the preparation method of [2,3-b] pyridine compounds and their also | — | 1986-08-20 | — | — | CN | disclosed |
| EP-0066628-B1 | PYRIDINE DERIVATIVES | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1986-04-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250122172-A1 | SUBSTITUTED PYRIDINE AND PYRAZINE COMPOUNDS AS PDE4 INHIBITORS | PDE4A, PDE4B, PDE4D | NPC1 4405/4885CYP2D6 1023/4885CYP2C19 624/4885 |
| US-12199280-B2 | Non-aqueous secondary battery and non-aqueous electrolyte | CLK2, TYK2, CLK3 | NPC1 3125/4885CYP2D6 4271/4885CYP2C19 2909/4885 |
| US-20230286913-A1 | INHIBITORS OF NITRIC OXIDE SYNTHASES (NOS), PHARMACEUTICAL PRODUCTS THEREOF, AND METHODS THEREOF | NOS1, NOS3, NOS2 | NPC1 656/4885CYP2D6 360/4885CYP2C19 113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.